Vasundhara Bhargava

Vasundhara Bhargava is a Principal at Patient Square Capital. Ms. Bhargava has 10 years of investment and acquisition experience, most recently as a vice president at Golden Gate Capital. Earlier in her career, Ms. Bhargava was a private equity investor at GIC, and prior to that was an associate at TPG Capital, the private equity platform of alternative asset manager TPG. Prior to TPG, Ms. Bhargava was an analyst in the investment banking division at Goldman Sachs.

Ms. Bhargava currently serves on the Board of Directors of Apollo Therapeutics and is a Board Observer at Alladapt Immunotherapeutics.

Ms. Bhargava holds a bachelor’s degree in finance, a bachelor’s degree in economics, and a bachelor’s degree in mathematics from Indiana University. She also holds a master’s degree in business administration from Stanford’s Graduate School of Business.